Frontlight ResearchEarly access
Vitiligo trials in Portugal
1 of 1 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Active, not recruitingA Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo
- Where
- Coimbra, Lisbon, Porto
- Age
- 6 years to 11 years
- People
- 250 worldwide
- Run by
- Incyte Corporation
See details and how to joinNCT06804811 · EU 2024-513171-41-00